Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.92 +0.74%   SPY: 135.53 +0.25%
Quote Spy ASTM NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Aastrom Biosciences (ASTM)

@ 2:21 PM
Click the portfolio to add ASTM:
Close [X]
+ Add ASTM to Portfolio
  
  Last Trade: $1.88 -0.07 (-3.59%)
  Volume: 252,247 137% of avg daily volume
       
  Avg Volume: 209,975
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 1.85 - 1.94
  Open: 1.94
  Previous Close: 1.95
  52-wk Range: 1.75 - 3.47
  Market Cap: 76.4M
  P/E: -3.1
  Div Yield: $0.00 (0.00%)
Indexes
Stem Cell Stocks (+1.5%)
Spy ASTM

? Pro holders
? Member holders
? Items submitted
Additional ASTM resources



Customize Links
To see which Pros and tickerspy members own ASTM Sign up now
Latest ASTM Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Aastrom Biosciences to Present at Piper Jaffray 23rd Annual Health Care Conference in New York City
ASTM  
Linked by GlobeNewswire - November 22, 04:05PM from (www.globenewswire.com)
ANN ARBOR, Mich., Nov. 22, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Aastrom Reports Positive 12-Month Results from the RESTORE-CLI Phase 2 Clinical Trial for Ixmyelocel-T in Patients with Critical Limb Ischemia
ASTM  
Linked by GlobeNewswire - November 14, 11:15AM from (www.globenewswire.com)
ANN ARBOR, Mich., Nov. 14, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Aastrom Biosciences to Hold Research and Development Day Review for Investors on November 17, 2011
ASTM  
Linked by GlobeNewswire - November 11, 04:05PM from (www.globenewswire.com)
ANN ARBOR, Mich., Nov. 11, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Aastrom Biosciences Reports Third Quarter 2011 Financial Results
ASTM  
Linked by GlobeNewswire - November 08, 04:05PM from (www.globenewswire.com)
ANN ARBOR, Mich., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
New York Academy of Sciences Symposium on Advances in Adult Stem Cell Therapy in Tissue Repair for Cardiovascular Diseases to Feature Aastrom Biosciences
ASTM  
Linked by GlobeNewswire - November 03, 09:00AM from (www.globenewswire.com)
ANN ARBOR, Mich., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Final 12-Month Results From the Aastrom RESTORE-CLI Phase 2b Clinical Trial to be Presented at the American Heart Association Scientific Sessions 2011 on Monday, November 14, 2011
ASTM  
Linked by GlobeNewswire - November 01, 04:05PM from (www.globenewswire.com)
ANN ARBOR, Mich., Nov. 1, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Webcast Alert: Aastrom to Host Third Quarter 2011 Investor Call on Tuesday, November 8, 2011
ASTM  
Linked by GlobeNewswire - October 31, 04:05PM from (www.globenewswire.com)
ANN ARBOR, Mich., Oct. 31, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Aastrom Appoints Brian Gibson as Vice President, Finance
ASTM  
Linked by GlobeNewswire - October 13, 04:05PM from (www.globenewswire.com)
ANN ARBOR, Mich., Oct. 13, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Aastrom Granted European Composition-of-Matter Patent for Ixmyelocel-T
ASTM  
Linked by GlobeNewswire - October 03, 09:00AM from (www.globenewswire.com)
ANN ARBOR, Mich., Oct. 3, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Aastrom to Present at the Sixth Annual JMP Securities Healthcare Conference
ASTM  
Linked by GlobeNewswire - September 23, 09:00AM from (www.globenewswire.com)
ANN ARBOR, Mich., Sept. 23, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 13



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource